Michaela S. Meyer

Erwin Rommel Str. 1
Erlangen, BY 91058, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 158 publications

Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling.

Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling.

Journal: CPT: pharmacometrics & systems pharmacology

Published: March 02, 2026

Measurement of Reactor Antineutrino Oscillation at SNO.

Measurement of Reactor Antineutrino Oscillation at SNO.

Journal: Physical review letters

Published: May 07, 2025

Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 2: in vivo pharmacokinetic modeling of vericiguat.

Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 2: in vivo pharmacokinetic modeling of vericiguat.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: March 28, 2025

Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 1: in vitro modeling of vericiguat.

Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 1: in vitro modeling of vericiguat.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: January 24, 2025

Safety and tolerability of the M2 muscarinic acetylcholine receptor modulator BAY 2413555 in heart failure with reduced ejection fraction in the REMOTE-HF study.

Safety and tolerability of the M2 muscarinic acetylcholine receptor modulator BAY 2413555 in heart failure with reduced ejection fraction in the REMOTE-HF study.

Journal: Scientific reports

Published: July 27, 2024

High-Statistics Measurement of the Cosmic-Ray Electron Spectrum with H.E.S.S.

High-Statistics Measurement of the Cosmic-Ray Electron Spectrum with H.E.S.S.

Journal: Physical review letters

Published: June 15, 2024

Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat.

Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat.

Journal: Clinical pharmacokinetics

Published: May 08, 2024

NT-proBNP for Predicting All-Cause Death and Heart Transplant in Children and Adults with Heart Failure.

NT-proBNP for Predicting All-Cause Death and Heart Transplant in Children and Adults with Heart Failure.

Journal: Pediatric cardiology

Published: January 30, 2024

Assessing QTc Effects of Vericiguat Using Two Different Concentration-QTc Modeling Approaches.

Assessing QTc Effects of Vericiguat Using Two Different Concentration-QTc Modeling Approaches.

Journal: Clinical pharmacokinetics

Published: June 25, 2023

Applied physiologically-based pharmacokinetic modeling to assess uridine diphosphate-glucuronosyltransferase-mediated drug-drug interactions for Vericiguat.

Applied physiologically-based pharmacokinetic modeling to assess uridine diphosphate-glucuronosyltransferase-mediated drug-drug interactions for Vericiguat.

Journal: CPT: pharmacometrics & systems pharmacology

Published: June 13, 2023

Isotope effects in dynamics of water isotopologues induced by core ionization at an x-ray free-electron laser.

Isotope effects in dynamics of water isotopologues induced by core ionization at an x-ray free-electron laser.

Journal: Structural dynamics (Melville, N.Y.)

Published: June 01, 2023

Electronic health record characterization and outcomes of heart failure with preserved ejection fraction.

Electronic health record characterization and outcomes of heart failure with preserved ejection fraction.

Journal: American heart journal

Published: April 20, 2023

Showing 1-12 of 158

Last Updated: 09/26/2026